Clinical genetic analysis and diagnosis of a family with hereditary hemorrhagic telangiectasia.
10.3760/cma.j.cn115330-20210323-00143
- Author:
Xiao Yu SONG
1
;
Yu Juan YANG
2
;
Yao YAO
1
;
Yu ZHANG
2
;
Xi Cheng SONG
1
Author Information
1. Department of Otorhinolaryngology Head and Neck Surgery, Yuhuangding Hospital of Qingdao University, Yantai 264000, Shandong Province, China.
2. Taishan Scholar Laboratory, Yuhuangding Hospital of Qingdao University, Yantai 264000, Shandong Province, China.
- Publication Type:Journal Article
- MeSH:
Activin Receptors, Type II/genetics*;
Endoglin/genetics*;
Genetic Testing;
Humans;
Mutation;
Sequence Analysis;
Telangiectasia, Hereditary Hemorrhagic/genetics*
- From:
Chinese Journal of Otorhinolaryngology Head and Neck Surgery
2021;56(12):1307-1312
- CountryChina
- Language:Chinese
-
Abstract:
Objective: To explore the diagnostic significance of the combination of clinical and genetic detection of hereditary hemorrhagic telangiectasia (HHT) by analyzing the clinical and genetic diagnosis of a family with HHT. Methods: Medical history data of the probands and their family members were collected, and the sequence analyses of coding regions of ENG, ACVRL1, SMAD4 and GDF2 genes were performed by PCR-sequencing method, and a comprehensive diagnosis was made based on the clinical features and gene detection results. After the pathogenic gene variation was identified, 11 members of 3 generations of the family were tested for pathogenic gene mutation. Results: There was an ACVRL1 c.715_716delAG mutation in the proband and 9 other family members, which caused p.S239C. Based on the clinical and genetic findings, the 7 suspected were diagnosed and 2 asymptomatic patients were found to carry the mutation site. Conclusion: The combination of clinical features and gene detection can determine the etiology and classification of HHT, which is convenient for the early diagnosis and prevention of the disease.
